Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Filosto

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Journal of Medical Genetics|June 3, 2004
A mitochondrial DNA duplication as a marker of skeletal muscle specific mutations in the mitochondrial genomeM Mancuso, C Vives-Bauza, M Filosto, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 18, 2009
Chronic ophthalmoparesis in limb girdle muscular dystrophy 1CM Filosto, P Tonin, G Vattemi, et al.
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology|November 24, 2011
Clinical, morphological and genetic studies in a cohort of 21 patients with myofibrillar myopathyG Vattemi, M Neri, S Piffer, et al.
Brain Pathology (Zurich, Switzerland)|April 17, 2001
Increased expression of the normal cellular isoform of prion protein in inclusion-body myositis, inflammatory myopathies and denervation atrophyG Zanusso, G Vattemi, S Ferrari, et al.
Current Molecular Medicine|June 5, 2014
Myopathic involvement and mitochondrial pathology in Kennedy disease and in other motor neuron diseasesD Orsucci, A Rocchi, E Caldarazzo Ienco, et al.
European Journal of Neurology|January 31, 2026
EAN 2024 Guideline on the Diagnostic Approach to Oligo/Asymptomatic HyperCKemiaT Kyriakides, K Aleksovska, C Angelini, et al.
Journal of Neurology|July 14, 2021
Adult-onset mitochondrial movement disorders: a national picture from the Italian NetworkV Montano, D Orsucci, V Carelli, et al.
Neuropathology and Applied Neurobiology|June 3, 2017
Effects of short-to-long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD)M Ripolone, R Violano, D Ronchi, et al.
Journal of Neurology|July 11, 2025
Analysis of the Italian cohort of late-onset Pompe disease (LOPD) patients after 10 and 15 years of therapy with alglucosidase alfaT Mongini, G Gadaleta, P Alonge, et al.
Journal of Neurology|November 15, 2011
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 yearsC Angelini, C Semplicini, S Ravaglia, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of Medical Genetics|June 3, 2004
A mitochondrial DNA duplication as a marker of skeletal muscle specific mutations in the mitochondrial genomeM Mancuso, C Vives-Bauza, M Filosto, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 18, 2009
Chronic ophthalmoparesis in limb girdle muscular dystrophy 1CM Filosto, P Tonin, G Vattemi, et al.
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology|November 24, 2011
Clinical, morphological and genetic studies in a cohort of 21 patients with myofibrillar myopathyG Vattemi, M Neri, S Piffer, et al.
Brain Pathology (Zurich, Switzerland)|April 17, 2001
Increased expression of the normal cellular isoform of prion protein in inclusion-body myositis, inflammatory myopathies and denervation atrophyG Zanusso, G Vattemi, S Ferrari, et al.
Current Molecular Medicine|June 5, 2014
Myopathic involvement and mitochondrial pathology in Kennedy disease and in other motor neuron diseasesD Orsucci, A Rocchi, E Caldarazzo Ienco, et al.
European Journal of Neurology|January 31, 2026
EAN 2024 Guideline on the Diagnostic Approach to Oligo/Asymptomatic HyperCKemiaT Kyriakides, K Aleksovska, C Angelini, et al.
Journal of Neurology|July 14, 2021
Adult-onset mitochondrial movement disorders: a national picture from the Italian NetworkV Montano, D Orsucci, V Carelli, et al.
Neuropathology and Applied Neurobiology|June 3, 2017
Effects of short-to-long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD)M Ripolone, R Violano, D Ronchi, et al.
Journal of Neurology|July 11, 2025
Analysis of the Italian cohort of late-onset Pompe disease (LOPD) patients after 10 and 15 years of therapy with alglucosidase alfaT Mongini, G Gadaleta, P Alonge, et al.
Journal of Neurology|November 15, 2011
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 yearsC Angelini, C Semplicini, S Ravaglia, et al.
Pageof 4